US Patent 9035063 Compounds as rearranged during transfection (RET) inhibitors
Patent 9035063 was granted and assigned to GlaxoSmithKline on May, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9035063 Compounds as rearranged during transfection (RET) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
